Last reviewed · How we verify
Warner Chilcott LLC Sarafem Tablets — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Warner Chilcott LLC Sarafem Tablets (Warner Chilcott LLC Sarafem Tablets) — Torrent Pharmaceuticals Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Warner Chilcott LLC Sarafem Tablets TARGET | Warner Chilcott LLC Sarafem Tablets | Torrent Pharmaceuticals Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Warner Chilcott LLC Sarafem Tablets CI watch — RSS
- Warner Chilcott LLC Sarafem Tablets CI watch — Atom
- Warner Chilcott LLC Sarafem Tablets CI watch — JSON
- Warner Chilcott LLC Sarafem Tablets alone — RSS
Cite this brief
Drug Landscape (2026). Warner Chilcott LLC Sarafem Tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/warner-chilcott-llc-sarafem-tablets. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing